Juan Jesús
Cruz Hernández
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clinico Universitario de Valencia (9)
2019
-
Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population
Cancers, Vol. 11, Núm. 4
2017
-
Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma
Scientific Reports, Vol. 7, Núm. 1
2016
-
Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location
Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1114-1122
-
Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population
Oral Oncology, Vol. 63, pp. 38-43
-
Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study
Oral Oncology, Vol. 62, pp. 54-59
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558
2014
-
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers
Breast Cancer Research and Treatment, Vol. 148, Núm. 2, pp. 415-421
2003
-
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects
Human Mutation, Vol. 22, Núm. 4, pp. 301-312
1995
-
A phase II trial of weekly high dose continuous infusion 5‐fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
Cancer, Vol. 76, Núm. 4, pp. 559-563